Testosterone Levels Following Decreases in Serum Osteocalcin

[1]  S. Cummings,et al.  Effects of antiresorptive therapies on glucose metabolism: Results from the FIT, HORIZON‐PFT, and FREEDOM trials , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  I. Kanazawa,et al.  Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus , 2013, Osteoporosis International.

[3]  B. Clarke.  Change in Undercarboxylated Osteocalcin Is Associated with Changes in Body Weight, Fat Mass, and Adiponectin: Parathyroid Hormone (1-84) or Alendronate Therapy in Postmenopausal Women with Osteoporosis (the PaTH Study) , 2012 .

[4]  B. L. Riggs,et al.  Relationship of testosterone and osteocalcin levels during growth , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  G. Sumara,et al.  Endocrine Regulation of Male Fertility by the Skeleton , 2011, Cell.

[6]  D. Mellström,et al.  Plasma Osteocalcin Is Inversely Related to Fat Mass and Plasma Glucose in Elderly Swedish Men , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  B. Dawson-Hughes,et al.  Association between serum osteocalcin and markers of metabolic phenotype. , 2009, The Journal of clinical endocrinology and metabolism.

[8]  I. Reid,et al.  Effects of Intravenous Zoledronate on Bone Turnover and BMD Persist for at Least 24 Months , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  M. McKee,et al.  Endocrine Regulation of Energy Metabolism by the Skeleton , 2007, Cell.

[10]  I. Reid,et al.  Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial. , 2007, The Journal of clinical endocrinology and metabolism.

[11]  I. Reid.  Relationships among body mass, its components, and bone. , 2002, Bone.

[12]  Jacques P. Brown,et al.  Intravenous zoledronic acid in postmenopausal women with low bone mineral density. , 2002, The New England journal of medicine.